NO930284L - Pyridinderivater, fremgangsmaate for deres fremstilling oganvendelse derav - Google Patents

Pyridinderivater, fremgangsmaate for deres fremstilling oganvendelse derav

Info

Publication number
NO930284L
NO930284L NO93930284A NO930284A NO930284L NO 930284 L NO930284 L NO 930284L NO 93930284 A NO93930284 A NO 93930284A NO 930284 A NO930284 A NO 930284A NO 930284 L NO930284 L NO 930284L
Authority
NO
Norway
Prior art keywords
procedure
preparation
pyridine derivatives
derivatives
pyridinoline
Prior art date
Application number
NO93930284A
Other languages
English (en)
Other versions
NO180779C (no
NO180779B (no
NO930284D0 (no
Inventor
Laszlo Revesz
Rudolf Waelchli
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO930284D0 publication Critical patent/NO930284D0/no
Publication of NO930284L publication Critical patent/NO930284L/no
Publication of NO180779B publication Critical patent/NO180779B/no
Publication of NO180779C publication Critical patent/NO180779C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Soft Magnetic Materials (AREA)
  • Paper (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO930284A 1992-01-31 1993-01-28 Pyridinderivater, fremgangsmåte for deres fremstilling, anvendelse derav, sett omfattende slike, og utgangsforbindelse for fremgangsmåten NO180779C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929202139A GB9202139D0 (en) 1992-01-31 1992-01-31 Improvements in or relating to organic compounds

Publications (4)

Publication Number Publication Date
NO930284D0 NO930284D0 (no) 1993-01-28
NO930284L true NO930284L (no) 1993-08-02
NO180779B NO180779B (no) 1997-03-10
NO180779C NO180779C (no) 1997-06-18

Family

ID=10709643

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930284A NO180779C (no) 1992-01-31 1993-01-28 Pyridinderivater, fremgangsmåte for deres fremstilling, anvendelse derav, sett omfattende slike, og utgangsforbindelse for fremgangsmåten

Country Status (16)

Country Link
EP (1) EP0556152B1 (no)
JP (1) JP3544549B2 (no)
AT (1) ATE210645T1 (no)
AU (1) AU663909B2 (no)
CA (1) CA2088396A1 (no)
CZ (1) CZ288038B6 (no)
DE (1) DE69331293T2 (no)
DK (1) DK0556152T3 (no)
ES (1) ES2169723T3 (no)
FI (1) FI104896B (no)
GB (1) GB9202139D0 (no)
HU (1) HU214677B (no)
NO (1) NO180779C (no)
PT (1) PT556152E (no)
SG (1) SG43065A1 (no)
SK (1) SK281137B6 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620861A (en) * 1992-07-31 1997-04-15 Metra Biosystems, Inc. Method and kit for pyridinium crosslink assay
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5736344A (en) * 1992-12-17 1998-04-07 Metra Biosystems, Inc. Serum pyridinium crosslinks assay
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
US5723619A (en) * 1997-01-13 1998-03-03 Bayer Corporation Method for the synthesis of deoxypyridinoline
US5834610A (en) * 1997-05-06 1998-11-10 Johnson; Gary M. Conversion of pyridinoline to deoxypyridinoline
CN105801688A (zh) * 2016-04-14 2016-07-27 苏州博源医疗科技有限公司 脱氧吡啶酚免疫原、抗体和检测试剂及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59148766A (ja) * 1983-02-10 1984-08-25 Otsuka Pharmaceut Co Ltd ピリジン誘導体
US4973666A (en) * 1987-11-06 1990-11-27 Washington Research Foundation Peptide fragments containing HP and LP cross-links
GB8929366D0 (en) * 1989-12-30 1990-02-28 Rowett Research Inst Method to detect connective tissue disorder in humans and animals

Also Published As

Publication number Publication date
CZ288038B6 (cs) 2001-04-11
CZ10693A3 (en) 1993-12-15
EP0556152A1 (en) 1993-08-18
SG43065A1 (en) 1997-10-17
EP0556152B1 (en) 2001-12-12
HU9300108D0 (en) 1993-04-28
JPH0641078A (ja) 1994-02-15
DK0556152T3 (da) 2002-04-08
NO180779C (no) 1997-06-18
SK281137B6 (sk) 2000-12-11
AU663909B2 (en) 1995-10-26
ATE210645T1 (de) 2001-12-15
NO180779B (no) 1997-03-10
CA2088396A1 (en) 1993-08-01
DE69331293D1 (de) 2002-01-24
JP3544549B2 (ja) 2004-07-21
DE69331293T2 (de) 2002-07-18
FI930367A (fi) 1993-08-01
PT556152E (pt) 2002-05-31
FI930367A0 (fi) 1993-01-28
FI104896B (fi) 2000-04-28
GB9202139D0 (en) 1992-03-18
SK4293A3 (en) 1993-11-10
AU3210593A (en) 1993-08-05
ES2169723T3 (es) 2002-07-16
HUT70276A (en) 1995-09-28
NO930284D0 (no) 1993-01-28
HU214677B (hu) 1998-04-28

Similar Documents

Publication Publication Date Title
DE69418243D1 (de) N-Heteroaryl-N'-Phenylharnstoffderivate, ihre Herstellung und Verwendung
BR8704582A (pt) Processo para preparar derivados de piridinacarboxamida
FI935672A0 (fi) Substituerade pyrazoler
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
NO930284D0 (no) Pyridinderivater, fremgangsmaate for deres fremstilling oganvendelse derav
PT93673A (pt) Processo para a preparacao de derivados da piridina
ES2082882T3 (es) Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos.
ES2082890T3 (es) Procedimiento para la preparacion de derivados 6-(aminopropionilo sustituido) de forskolina.
PT97692A (pt) Processo para a preparacao de derivados heterociclicos antagonistas de nmda (acido n-metil-d-aspartico)
DK0381114T3 (da) Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
DE69127238D1 (de) Verfahren zur Herstellung von Pyrido[1,2-a]pyrimidinderivaten
ES2002325A6 (es) Un procedimiento para preparar un derivado de dihidropiridina